The Cochrane collaboration has recently published a systematic review of placebo controlled randomized trials of herbal therapies for rheumatoid arthritis. An extensive search including all languages screened 2500 hits, identified 47 trials and accepted 11 as meeting set quality criteria. Modest efficacy of gamma linolenic acid containing products was supported by 7 trials, 4 trials dealt with 4 different products, and no conclusions could be derived from these. Although it was stated in the review that safety was probably good, this is not apparent from the presented material.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Response of Carbon Storage Evolution to Future Climate and Policy at the Basin Scale].
Huan Jing Ke Xue
December 2024
Hunan Provincial Key Laboratory for Eco-environmental Changes and Carbon Sequestration of the Dongting Lake Basin, School of Geographic Sciences, Hunan Normal University, Changsha 410081, China.
In this study, we explored the impact of land-use changes on carbon sinks in terrestrial ecosystems from a watershed perspective under the backdrop of "carbon peak and neutrality." This will provide robust support for scientific decision-making and the sustainable development of integrated watershed management. Watershed ecosystems encompass natural, social, and economic dimensions and are crucial for improving regional ecological quality and ensuring sustainable development.
View Article and Find Full Text PDFReimagining Support for Autistic Indigenous Children in the United States: Addressing Under-Identification and Service Gaps.
Neuropsychiatr Dis Treat
August 2024
Dr. Love's Healthcare®, Integrative Nutrition and Lifestyle Medicine, Cedar Hill, TX, USA.
Although the original purpose of this article was to provide a comprehensive review of services provided for autistic children among Indigenous communities in Texas, USA, the authors' encounter with a significant paucity in availability of data and relevant reports on Indigenous services for ASD spurred the choice of a perspective article instead as it allows a more critical view into the pitfalls surrounding the state of autism services. The meager documentation availability presents a dilemma for both researchers and Indigenous communities since it often leads to misrepresentations of data, and limits understanding of existing support systems. This perspective article addresses these issues and serves to highlight the complexity of collecting data among Indigenous populations across the United States.
View Article and Find Full Text PDFUnderstanding Child Abuse and Neglect Indications: Insights From Medical Students.
Cureus
June 2024
Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, SAU.
Background: Child abuse is a severe issue that impacts medical professionals and patients globally. It can lead to discomfort, risk, or even the demise of a child. One of the most significant facets of a doctor's work involves providing aid to those in need; since children are more dependent on others for care and safety, they should receive attention that is even more special in quality.
View Article and Find Full Text PDFCryptic late-onset myocarditis after coronavirus vaccination.
FASEB J
July 2024
Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
As we enter a new era of mRNA-based therapeutics, evidence on genetic or environmental factors that might predispose to unknown off-target side effects, gains in importance. Among these factors, exercise appears likely to have influenced otherwise cryptic cases of early-onset postvaccination myocarditis. And the existence of a distinct late-onset myocarditis is now being recognized.
View Article and Find Full Text PDFAssessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials.
Cancer Med
May 2024
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA.
Objective: This study aims to evaluate published clinical trials of ramucirumab to assess the risk/benefit profile and burden over time for patients.
Background: The burden of oncologic drug development on patients paired with increasing clinical trial failure rates emphasizes the need for reform of drug development. Identifying and addressing patterns of excess burden can guide policy, ensure evidence-based protections for trial participants, and improve medical decision-making.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!